Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology

被引:1
作者
Andrews, JM [1 ]
Ashby, JP [1 ]
Jevons, G [1 ]
Wise, R [1 ]
机构
[1] City Hosp, Dept Microbiol, Birmingham B18 7QH, W Midlands, England
关键词
ABT-492; susceptibility; BSAC method;
D O I
10.1093/jac/dkg328
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:526 / 527
页数:2
相关论文
共 5 条
[1]   Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria [J].
Andrews, JM ;
Ashby, JP ;
Jevons, GM ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (06) :819-822
[2]  
[Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1
[3]  
*BRIT SOC ANT CHEM, 2001, J ANTIMICROBIAL SS1, V48, P43
[4]   Management of infections due to resistant enterococci: a review of therapeutic options [J].
Landman, D ;
Quale, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) :161-170
[5]  
NILIUS AM, 2002, 42 INT C ANT AG CHEM, P183